Traws Pharma, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAW and other ETFs, options, and stocks.About TRAW
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer.
CEOIain David Dukes
CEOIain David Dukes
Employees7
Employees7
HeadquartersNewtown, Pennsylvania
HeadquartersNewtown, Pennsylvania
Founded1998
Founded1998
Employees7
Employees7
TRAW Key Statistics
Market cap19.58M
Market cap19.58M
Price-Earnings ratio0.10
Price-Earnings ratio0.10
Dividend yield—
Dividend yield—
Average volume1.04M
Average volume1.04M
High today$2.50
High today$2.50
Low today$2.15
Low today$2.15
Open price$2.28
Open price$2.28
Volume526.68K
Volume526.68K
52 Week high$19.44
52 Week high$19.44
52 Week low$0.97
52 Week low$0.97
Stock Snapshot
As of today, Traws Pharma, Inc.(TRAW) shares are valued at $2.50. The company's market cap stands at 19.58M, with a P/E ratio of 0.10.
On 2025-11-25, Traws Pharma, Inc.(TRAW) stock traded between a low of $2.15 and a high of $2.50. Shares are currently priced at $2.50, which is +16.3% above the low and 0.0% below the high.
Traws Pharma, Inc.(TRAW) shares are trading with a volume of 526.68K, against a daily average of 1.04M.
In the last year, Traws Pharma, Inc.(TRAW) shares hit a 52-week high of $19.44 and a 52-week low of $0.97.
In the last year, Traws Pharma, Inc.(TRAW) shares hit a 52-week high of $19.44 and a 52-week low of $0.97.
People also own
Based on the portfolios of people who own TRAW. This list is generated using Robinhood data, and it’s not a recommendation.